DALLAS— Prosecutors say a North Texas man who helped smuggle what he thought was cocaine onto flights from Dallas-Fort Worth International Airport must serve nearly 16 years in prison. Moniteveti "Vince" Katoa was sentenced Thursday in Dallas. The packages were flown to Las Vegas, Phoenix, Chicago and San Francisco, plus Newark, New Jersey, and Wichita, Kansas.
According to the lawsuit by the states, Indivior told the FDA that it planned to offer a new "sublingual film," or dissolvable strip version of the drug, which had been licensed to Indivior by MonoSol Rx. The lawsuit claims that the company persuaded the FDA to approve the strip by raising concerns that the tablet posed high exposure risks to children.
According to the lawsuit by the states, Indivior told the FDA that it planned to offer a new "sublingual film," or dissolvable strip version of the drug, which had been licensed to Indivior by MonoSol. The lawsuit claims that the company persuaded the FDA to approve the strip by raising concerns that the tablet posed high exposure risks to children.
Former FDA Deputy Commissioner Scott Gottlieb, M.D. weighs in on Mylan's pricing outrage and what's really driving drug price hikes.
Philippine President Rodrigo Duterte invited UN Secretary-General Ban Ki-moon and the European Union to investigate his anti-drugs crackdown.
Sarepta soars on FDA approval. Stephen Weiss, Short Hills Captial, discusses how investors should approach the name.
Wells Fargo's $185 million settlement, and Mylan's EpiPen mess were about corporate greed, the Aspen Institute CEO says.
For more than a decade, members of a little-known group called the Pain Care Forum have blanketed Washington with messages touting prescription painkillers' vital role in the lives of millions of Americans, creating an echo chamber that has quietly derailed efforts to curb U.S. consumption of the drugs, which accounts for two-thirds of the world's usage.
But the next president could have his or her hands full, dealing with Iran in general and the agreement in particular. For Hillary Clinton and Donald Trump, it's basically a question of continuity versus change. She supports it, while taking a generally tougher tone on Iran than President Barack Obama.
A serious warning on Pfizer's quit smoking drug should be removed, panelists to the U.S. Food and Drug Administration recommended on Wednesday.
Pfizer's Chantix was approved about a decade ago, but thousands of reports of mental health problems in users led to the FDA imposing the "black box" warning- the most severe available- in 2009.. Pfizer failed a previous attempt to get rid of the boxed warning, after the FDA went along with a panel recommendation in 2014 to retain it pending the outcome of the...
David Maris, Wells Fargo Securities, and CNBC's Meg Tirrell talk about rebates, the outrage over drug prices and Hillary Clinton's drug price plan.
CNBC's Meg Tirrell reports on how Hillary Clinton's policies on drug pricing will impact the industry and investors.
CNBC's John Harwood reports on Hillary Clinton's new plan aimed to tackle drug price hikes.
Mylan's EpiPen price hike is just the latest in a series of "poor management" decisions by the board, NYC Comptroller Scott Stringer tells CNBC.
Aug 31- The U.S. Food and Drug Administration on Wednesday strengthened warnings about the danger of combining opioid painkillers or cough medicines containing opioids with benzodiazepines, a common class of sedatives. "It is nothing short of a public health crisis when you see a substantial increase of avoidable overdose and death related to two widely used...
The Philippine President will be meeting Barack Obama in Laos next week on the sidelines of an East Asia summit.
Opioids now kill more people than auto accidents or guns. What can be done to curb this epidemic, with U.S. Surgeon General Vivek Murthy.
The only way to stop drug companies from jacking up the costs of live-saving treatments is through price controls, a former Obama health advisor says.
Chief pharmacy officer at the Cleveland Clinic discusses Mylan's "generic" version of its own product, the Epipen, on CNBC's "Closing Bell."